Task force: adverse drug events: prescriptions.

The Pharmacy Law provides for the licensure and regulation of the practice of pharmacy by the California State Board of Pharmacy. Existing law prohibits a pharmacist from dispensing a prescription unless the prescription container contains specified information, including the condition or purpose for which the drug was prescribed if the condition or purpose is indicated on the prescription. This bill would create the Prescription Labeling and Adverse Drug Event Prevention Advisory Task Force, with membership as prescribed, to develop information, make recommendations, and report findings to the California State Board of Pharmacy, the Medical Board of California, and the Legislature on matters relating to the inclusion of the condition or purpose for which a drug is prescribed on prescription labels and adverse drug events. The bill would require each board, following submission of the report, to adopt regulations to implement recommendations in the report that are within the jurisdiction of the relevant board to enact through regulation if, in the independent determination of the board, the regulations will achieve the goals of improving the patient opt-in process, increasing the prevalence of patient opt-ins, as defined, and reducing the prevalence of adverse drug events.